H W Cohen1, C Shmukler, R Ullman, C M Rivera, E A Walker. 1. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. hicohen@aecom.yu.edu
Abstract
AIMS: To assess pharmacy claims and self-report data as measures of medication adherence and to describe baseline characteristics of subjects in the Improving Diabetes Outcomes Study. METHODS:Multi-ethnic, lower-income, insured adults (n = 526) in New York City with Type 2 diabetes were enrolled in a randomized, controlled, behavioural intervention study delivered by telephone. Baseline data were examined, including glycated haemoglobin (HbA(1c)), objective measures of diabetes medication adherence [claims data medication possession ratio (MPR)], and two self-report measures [Morisky Medication-taking Scale and the medication-taking item of the Summary of Diabetes Self-Care Activities (SDSCA)]. Associations of highest tertile HbA(1c) (>or= 9.3%) with lowest tertile MPR (< 42%) were assessed with logistic regression models adjusting for potential confounders. Subset analyses were performed based on assessment of potential interaction. RESULTS:Participants (mean +/- sd age 56 +/- 7 years) had median (interquartile range) HbA(1c) 8.6% (8.0-10.0). Correlations of baseline MPR with Morisky score and SDSCA medication-taking item were strongly significant (both rho = 0.21, P < 0.001). Lowest MPR was significantly (P = 0.008) associated with highest HbA(1c) in the group as a whole and among the subset taking two or more oral glucose-lowering agents (OGLA) (P = 0.002), but not among the subset taking only one (P = 0.83). Self-report adherence measures were not significantly associated with HbA(1c) in either the whole group or either subset. CONCLUSIONS: These results support the validity of MPR as an adherence measure for OGLA among insured diabetes patients with poorly controlled HbA(1c), especially those taking two or more OGLA.
RCT Entities:
AIMS: To assess pharmacy claims and self-report data as measures of medication adherence and to describe baseline characteristics of subjects in the Improving Diabetes Outcomes Study. METHODS: Multi-ethnic, lower-income, insured adults (n = 526) in New York City with Type 2 diabetes were enrolled in a randomized, controlled, behavioural intervention study delivered by telephone. Baseline data were examined, including glycated haemoglobin (HbA(1c)), objective measures of diabetes medication adherence [claims data medication possession ratio (MPR)], and two self-report measures [Morisky Medication-taking Scale and the medication-taking item of the Summary of Diabetes Self-Care Activities (SDSCA)]. Associations of highest tertile HbA(1c) (>or= 9.3%) with lowest tertile MPR (< 42%) were assessed with logistic regression models adjusting for potential confounders. Subset analyses were performed based on assessment of potential interaction. RESULTS:Participants (mean +/- sd age 56 +/- 7 years) had median (interquartile range) HbA(1c) 8.6% (8.0-10.0). Correlations of baseline MPR with Morisky score and SDSCA medication-taking item were strongly significant (both rho = 0.21, P < 0.001). Lowest MPR was significantly (P = 0.008) associated with highest HbA(1c) in the group as a whole and among the subset taking two or more oral glucose-lowering agents (OGLA) (P = 0.002), but not among the subset taking only one (P = 0.83). Self-report adherence measures were not significantly associated with HbA(1c) in either the whole group or either subset. CONCLUSIONS: These results support the validity of MPR as an adherence measure for OGLA among insured diabetespatients with poorly controlled HbA(1c), especially those taking two or more OGLA.
Authors: Manel Pladevall; L Keoki Williams; Lisa Ann Potts; George Divine; Hugo Xi; Jennifer Elston Lafata Journal: Diabetes Care Date: 2004-12 Impact factor: 19.112
Authors: Audie A Atienza; Amy L Yaroch; Louise C Mãsse; Richard P Moser; Bradford W Hesse; Abby C King Journal: Am J Prev Med Date: 2006-11 Impact factor: 5.043
Authors: Elliott M Blass; Daniel R Anderson; Heather L Kirkorian; Tiffany A Pempek; Iris Price; Melanie F Koleini Journal: Physiol Behav Date: 2006-07-05
Authors: Chandra Y Osborn; Kerri Cavanaugh; Kenneth A Wallston; Sunil Kripalani; Tom A Elasy; Russell L Rothman; Richard O White Journal: J Health Commun Date: 2011
Authors: Lindsay S Mayberry; Jeffrey S Gonzalez; Kenneth A Wallston; Sunil Kripalani; Chandra Y Osborn Journal: Diabetes Res Clin Pract Date: 2013-09-26 Impact factor: 5.602
Authors: Chandra Y Osborn; Kenneth A Wallston; Adam Shpigel; Kerri Cavanaugh; Sunil Kripalani; Russell L Rothman Journal: Patient Educ Couns Date: 2013-02-21
Authors: Marjolein M J Zanders; Harm R Haak; Myrthe P P van Herk-Sukel; Lonneke V van de Poll-Franse; Jeffrey A Johnson Journal: Diabetologia Date: 2015-02-01 Impact factor: 10.122
Authors: Shantanu Nundy; Anjuli Mishra; Patrick Hogan; Sang Mee Lee; Marla C Solomon; Monica E Peek Journal: Diabetes Educ Date: 2014-10-02 Impact factor: 2.140
Authors: Chris L Bryson; David H Au; Matthew L Maciejewski; John D Piette; Stephan D Fihn; George L Jackson; Mark Perkins; Edwin S Wong; Elizabeth M Yano; Chuan-Fen Liu Journal: J Gen Intern Med Date: 2013-01-31 Impact factor: 5.128